Martis Capital

About Martis Capital

Martis Capital is a private equity firm based in Washington, DC, and San Francisco, CA, focused on investing in leaders to transform healthcare. They aim to improve the quality of care and address complex challenges in the healthcare industry by partnering with founder-led companies and management teams to achieve shared growth objectives through bespoke strategies.

Products & Services

Investment Services:Providing financial and human capital to healthcare companies, offering resources, expertise, and confidence to fuel growth through transparent and tailored investment strategies.

Specialties

Healthcare Industry Transformation Founder-Led Company Growth Bespoke Investment Strategies Transparent Investing

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Equity Fund T: - FT: Private Equity Fund	A: 779000000 MR: - FA: $779 million FAN: 779000000	D: 2023-06-07 FD: 2023-06-07	2 investors

Private Equity Fund Latest

2023-06-07

$779.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

V

Vladimir Andonov

Managing Director of Business Development

A

Andrew Bartlow

Advisor - Talent, Value Creation

C

Chris Beall

Partner

M

Michael Bush

Vice President, Operations - Value Creation

P

Phillip Campbell

Director

O

Owen Davis

Managing Partner

View 24 more team members with Pro

Unlock Full Team Directory

Recent News

Martis Capital Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised